BBL
MRNA icon

Beck Bode LLC’s Moderna MRNA Stock Holding History

Beck Bode LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,842
Closed -$331K – 170
2022
Q4 		$331K Sell
1,842
-3,947
-68% -$645K 0.07% 131
2022
Q3 		$685K Sell
5,789
-112
-2% -$17K 0.15% 113
2022
Q2 		$843K Buy
5,901
+511
+9% +$73K 0.18% 97
2022
Q1 		$928K Buy
+5,390
New +$907K 0.21% 74
2021
Q3 		– Sell
-206
Closed -$48K – 213
2021
Q2 		$48K Buy
+206
New +$36.8K 0.01% 134
2020
Q4 		– Sell
-100
Closed -$7K – 170
2020
Q3 		$7K Buy
+100
New +$6.97K ﹤0.01% 227

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Beck Bode LLC's MRNA Position: Q1 2023 in Review

Beck Bode LLC sold out of Moderna (MRNA) in Q1 2023, closing a stake of 1,842 shares — an estimated $331K sold.

Beck Bode LLC first reported a position in MRNA in Q3 2020 and held it in 6 quarters. The position peaked at $928K in Q1 2022. 1,016 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Beck Bode LLC reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Beck Bode LLC sold 1,842 Moderna shares in Q1 2023, an estimated $331K.
  • Beck Bode LLC first reported a position in Moderna in Q3 2020 and held it in 6 quarters.
  • Beck Bode LLC's Moderna position peaked at $928K in Q1 2022.
  • 1,016 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Beck Bode LLC's 13F filing for Q1 2023, filed 3 May 2023.